- Schrödinger’s new drug-discovery platform is recruiting front-end developers (JavaScript/Python/PHP) and claims it will “revolutionize” the field; the group is trying to determine whether the company’s internal models are validated with automated in-vitro/in-vivo data and whether they run continuous bioreactor pipelines to update simulation parameters.  
- A startup concept was proposed to sell microfluidic chips seeded with human skin-cell cultures to the cosmetics industry as an animal-testing replacement, sparking debate over whether Moore’s-law-driven simulation could soon make physical cell assays obsolete.  
- Participants explored biocompatible 3-D-printing materials beyond PLA, suggesting sucrose-based “sugar glass” and other photopolymers, and referenced a jmil guide on printing sugar glass.  
- Paperbot delivered several paywalled papers on request: a 1967 catalysis study (DOI 10.1016/0021-9517(67)90181-9), a Nature Biotechnology article on advanced biotech methods (DOI 10.1038/nbt.2746), and a Wiley paper on 3-D hydrogel scaffolds for guided cell growth (DOI 10.1002/adma.200803702).  
- A ScienceDaily article on recent biotech claims (http://www.sciencedaily.com/releases/2012/10/121002150031.htm) was shared and immediately met with skepticism, illustrating the channel’s habit of scrutinizing mainstream science reporting.